Global Orphan Drugs Industry Research Report, Competitive Landscape, Market Size, Regional Status and Prospect
Orphan drugs are special effects of rare diseases. Take the concept that the orphans are lonely and lacking attention.
The report combines extensive quantitative analysis and exhaustive qualitative analysis, ranges from a macro overview of the total market size, industry chain, and market dynamics to micro details of segment markets by type, application and region, and, as a result, provides a holistic view of, as well as a deep insight into the Orphan Drugs market covering all its essential aspects.
For the competitive landscape, the report also introduces players in the industry from the perspective of the market share, concentration ratio, etc., and describes the leading companies in detail, with which the readers can get a better idea of their competitors and acquire an in-depth understanding of the competitive situation. Further, mergers & acquisitions, emerging market trends, the impact of COVID-19, and regional conflicts will all be considered.
In a nutshell, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the market in any manner.
Key players in the global Orphan Drugs market are covered in Chapter 9:
F.Hoffman-La Roche AG
Shire PLC
AbbVie, Inc.
Celgene Corporation
Alexion
Sanofi
Johnson & Johnson Services, Inc.
Bayer
RegeneRX Biopharmaceuticals, Inc.
Brisol-Myers Squibb Company
Amryt Pharma PLC
Merck & Co. Inc.
Novartis AG
Pfizer Inc.
In Chapter 5 and Chapter 7.3, based on types, the Orphan Drugs market from 2017 to 2027 is primarily split into:
Oncologic Diseases
Metabolic Diseases
Hematologic and Immunologic Diseases
Infectious Diseases
Neurologic Diseases
Other Rare Diseases
In Chapter 6 and Chapter 7.4, based on applications, the Orphan Drugs market from 2017 to 2027 covers:
Non-Hodgkin Lymphoma
Acute Myeloid Leukemia
Cystic Fibrosis
Glioma
Pancreatic Cancer
Ovarian Cancer
Multiple Myeloma
Duchenne Muscular Dystrophy
Graft vs Host Disease
Renal Cell Carcinoma
Others
Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historical data and forecast (2017-2027) of the following regions are covered in Chapter 4 and Chapter 7:
United States
Europe
China
Japan
India
Southeast Asia
Latin America
Middle East and Africa
Client Focus
1. Does this report consider the impact of COVID-19 and the Russia-Ukraine war on the Orphan Drugs market?
Yes. As the COVID-19 and the Russia-Ukraine war are profoundly affecting the global supply chain relationship and raw material price system, we have definitely taken them into consideration throughout the research, and in Chapters 1.7, 2.7, 4.X.1, 7.5, 8.7, we elaborate at full length on the impact of the pandemic and the war on the Orphan Drugs Industry.
2. How do you determine the list of the key players included in the report?
With the aim of clearly revealing the competitive situation of the industry, we concretely analyze not only the leading enterprises that have a voice on a global scale, but also the regional small and medium-sized companies that play key roles and have plenty of potential growth.
Please find the key player list in Summary.
3. What are your main data sources?
Both Primary and Secondary data sources are being used while compiling the report.
Primary sources include extensive interviews of key opinion leaders and industry experts (such as experienced front-line staff, directors, CEOs, and marketing executives), downstream distributors, as well as end-users.
Secondary sources include the research of the annual and financial reports of the top companies, public files, new journals, etc. We also cooperate with some third-party databases.
Please find a more complete list of data sources in Chapters 11.2.1 & 11.2.2.
4. Can I modify the scope of the report and customize it to suit my requirements?
Yes. Customized requirements of multi-dimensional, deep-level and high-quality can help our customers precisely grasp market opportunities, effortlessly confront market challenges, properly formulate market strategies and act promptly, thus to win them sufficient time and space for market competition.
Outline
Chapter 1 mainly defines the market scope and introduces the macro overview of the industry, with an executive summary of different market segments ((by type, application, region, etc.), including the definition, market size, and trend of each market segment.
Chapter 2 provides a qualitative analysis of the current status and future trends of the market. Industry Entry Barriers, market drivers, market challenges, emerging markets, consumer preference analysis, together with the impact of the COVID-19 outbreak will all be thoroughly explained.
Chapter 3 analyzes the current competitive situation of the market by providing data regarding the players, including their sales volume and revenue with corresponding market shares, price and gross margin. In addition, information about market concentration ratio, mergers, acquisitions, and expansion plans will also be covered.
Chapter 4 focuses on the regional market, presenting detailed data (i.e., sales volume, revenue, price, gross margin) of the most representative regions and countries in the world.
Chapter 5 provides the analysis of various market segments according to product types, covering sales volume, revenue along with market share and growth rate, plus the price analysis of each type.
Chapter 6 shows the breakdown data of different applications, including the consumption and revenue with market share and growth rate, with the aim of helping the readers to take a close-up look at the downstream market.
Chapter 7 provides a combination of quantitative and qualitative analyses of the market size and development trends in the next five years. The forecast information of the whole, as well as the breakdown market, offers the readers a chance to look into the future of the industry.
Chapter 8 is the analysis of the whole market industrial chain, covering key raw materials suppliers and price analysis, manufacturing cost structure analysis, alternative product analysis, also providing information on major distributors, downstream buyers, and the impact of COVID-19 pandemic.
Chapter 9 shares a list of the key players in the market, together with their basic information, product profiles, market performance (i.e., sales volume, price, revenue, gross margin), recent development, SWOT analysis, etc.
Chapter 10 is the conclusion of the report which helps the readers to sum up the main findings and points.
Chapter 11 introduces the market research methods and data sources.
Years considered for this report:
Historical Years: 2017-2021
Base Year: 2021
Estimated Year: 2022
Forecast Period: 2022-2027
1 ORPHAN DRUGS MARKET OVERVIEW
1.1 Product Overview and Scope of Orphan Drugs Market
1.2 Orphan Drugs Market Segment by Type
1.2.1 Global Orphan Drugs Market Sales Volume and CAGR (%) Comparison by Type (2017-2027)
1.3 Global Orphan Drugs Market Segment by Application
1.3.1 Orphan Drugs Market Consumption (Sales Volume) Comparison by Application (2017-2027)
1.4 Global Orphan Drugs Market, Region Wise (2017-2027)
1.4.1 Global Orphan Drugs Market Size (Revenue) and CAGR (%) Comparison by Region (2017-2027)
1.4.2 United States Orphan Drugs Market Status and Prospect (2017-2027)
1.4.3 Europe Orphan Drugs Market Status and Prospect (2017-2027)
1.4.4 China Orphan Drugs Market Status and Prospect (2017-2027)
1.4.5 Japan Orphan Drugs Market Status and Prospect (2017-2027)
1.4.6 India Orphan Drugs Market Status and Prospect (2017-2027)
1.4.7 Southeast Asia Orphan Drugs Market Status and Prospect (2017-2027)
1.4.8 Latin America Orphan Drugs Market Status and Prospect (2017-2027)
1.4.9 Middle East and Africa Orphan Drugs Market Status and Prospect (2017-2027)
1.5 Global Market Size of Orphan Drugs (2017-2027)
1.5.1 Global Orphan Drugs Market Revenue Status and Outlook (2017-2027)
1.5.2 Global Orphan Drugs Market Sales Volume Status and Outlook (2017-2027)
1.6 Global Macroeconomic Analysis
1.7 The impact of the Russia-Ukraine war on the Orphan Drugs Market
2 INDUSTRY OUTLOOK
2.1 Orphan Drugs Industry Technology Status and Trends
2.2 Industry Entry Barriers
2.2.1 Analysis of Financial Barriers
2.2.2 Analysis of Technical Barriers
2.2.3 Analysis of Talent Barriers
2.2.4 Analysis of Brand Barrier
2.3 Orphan Drugs Market Drivers Analysis
2.4 Orphan Drugs Market Challenges Analysis
2.5 Emerging Market Trends
2.6 Consumer Preference Analysis
2.7 Orphan Drugs Industry Development Trends under COVID-19 Outbreak
2.7.1 Global COVID-19 Status Overview
2.7.2 Influence of COVID-19 Outbreak on Orphan Drugs Industry Development
3 GLOBAL ORPHAN DRUGS MARKET LANDSCAPE BY PLAYER
3.1 Global Orphan Drugs Sales Volume and Share by Player (2017-2022)
3.2 Global Orphan Drugs Revenue and Market Share by Player (2017-2022)
3.3 Global Orphan Drugs Average Price by Player (2017-2022)
3.4 Global Orphan Drugs Gross Margin by Player (2017-2022)
3.5 Orphan Drugs Market Competitive Situation and Trends
3.5.1 Orphan Drugs Market Concentration Rate
3.5.2 Orphan Drugs Market Share of Top 3 and Top 6 Players
3.5.3 Mergers & Acquisitions, Expansion
4 GLOBAL ORPHAN DRUGS SALES VOLUME AND REVENUE REGION WISE (2017-2022)
4.1 Global Orphan Drugs Sales Volume and Market Share, Region Wise (2017-2022)
4.2 Global Orphan Drugs Revenue and Market Share, Region Wise (2017-2022)
4.3 Global Orphan Drugs Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.4 United States Orphan Drugs Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.4.1 United States Orphan Drugs Market Under COVID-19
4.5 Europe Orphan Drugs Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.5.1 Europe Orphan Drugs Market Under COVID-19
4.6 China Orphan Drugs Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.6.1 China Orphan Drugs Market Under COVID-19
4.7 Japan Orphan Drugs Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.7.1 Japan Orphan Drugs Market Under COVID-19
4.8 India Orphan Drugs Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.8.1 India Orphan Drugs Market Under COVID-19
4.9 Southeast Asia Orphan Drugs Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.9.1 Southeast Asia Orphan Drugs Market Under COVID-19
4.10 Latin America Orphan Drugs Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.10.1 Latin America Orphan Drugs Market Under COVID-19
4.11 Middle East and Africa Orphan Drugs Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.11.1 Middle East and Africa Orphan Drugs Market Under COVID-19
5 GLOBAL ORPHAN DRUGS SALES VOLUME, REVENUE, PRICE TREND BY TYPE
5.1 Global Orphan Drugs Sales Volume and Market Share by Type (2017-2022)
5.2 Global Orphan Drugs Revenue and Market Share by Type (2017-2022)
5.3 Global Orphan Drugs Price by Type (2017-2022)
5.4 Global Orphan Drugs Sales Volume, Revenue and Growth Rate by Type (2017-2022)
5.4.1 Global Orphan Drugs Sales Volume, Revenue and Growth Rate of Oncologic Diseases (2017-2022)
5.4.2 Global Orphan Drugs Sales Volume, Revenue and Growth Rate of Metabolic Diseases (2017-2022)
5.4.3 Global Orphan Drugs Sales Volume, Revenue and Growth Rate of Hematologic and Immunologic Diseases (2017-2022)
5.4.4 Global Orphan Drugs Sales Volume, Revenue and Growth Rate of Infectious Diseases (2017-2022)
5.4.5 Global Orphan Drugs Sales Volume, Revenue and Growth Rate of Neurologic Diseases (2017-2022)
5.4.6 Global Orphan Drugs Sales Volume, Revenue and Growth Rate of Other Rare Diseases (2017-2022)
6 GLOBAL ORPHAN DRUGS MARKET ANALYSIS BY APPLICATION
6.1 Global Orphan Drugs Consumption and Market Share by Application (2017-2022)
6.2 Global Orphan Drugs Consumption Revenue and Market Share by Application (2017-2022)
6.3 Global Orphan Drugs Consumption and Growth Rate by Application (2017-2022)
6.3.1 Global Orphan Drugs Consumption and Growth Rate of Non-Hodgkin Lymphoma (2017-2022)
6.3.2 Global Orphan Drugs Consumption and Growth Rate of Acute Myeloid Leukemia (2017-2022)
6.3.3 Global Orphan Drugs Consumption and Growth Rate of Cystic Fibrosis (2017-2022)
6.3.4 Global Orphan Drugs Consumption and Growth Rate of Glioma (2017-2022)
6.3.5 Global Orphan Drugs Consumption and Growth Rate of Pancreatic Cancer (2017-2022)
6.3.6 Global Orphan Drugs Consumption and Growth Rate of Ovarian Cancer (2017-2022)
6.3.7 Global Orphan Drugs Consumption and Growth Rate of Multiple Myeloma (2017-2022)
6.3.8 Global Orphan Drugs Consumption and Growth Rate of Duchenne Muscular Dystrophy (2017-2022)
6.3.9 Global Orphan Drugs Consumption and Growth Rate of Graft vs Host Disease (2017-2022)
6.3.10 Global Orphan Drugs Consumption and Growth Rate of Renal Cell Carcinoma (2017-2022)
6.3.11 Global Orphan Drugs Consumption and Growth Rate of Others (2017-2022)
7 GLOBAL ORPHAN DRUGS MARKET FORECAST (2022-2027)
7.1 Global Orphan Drugs Sales Volume, Revenue Forecast (2022-2027)
7.1.1 Global Orphan Drugs Sales Volume and Growth Rate Forecast (2022-2027)
7.1.2 Global Orphan Drugs Revenue and Growth Rate Forecast (2022-2027)
7.1.3 Global Orphan Drugs Price and Trend Forecast (2022-2027)
7.2 Global Orphan Drugs Sales Volume and Revenue Forecast, Region Wise (2022-2027)
7.2.1 United States Orphan Drugs Sales Volume and Revenue Forecast (2022-2027)
7.2.2 Europe Orphan Drugs Sales Volume and Revenue Forecast (2022-2027)
7.2.3 China Orphan Drugs Sales Volume and Revenue Forecast (2022-2027)
7.2.4 Japan Orphan Drugs Sales Volume and Revenue Forecast (2022-2027)
7.2.5 India Orphan Drugs Sales Volume and Revenue Forecast (2022-2027)
7.2.6 Southeast Asia Orphan Drugs Sales Volume and Revenue Forecast (2022-2027)
7.2.7 Latin America Orphan Drugs Sales Volume and Revenue Forecast (2022-2027)
7.2.8 Middle East and Africa Orphan Drugs Sales Volume and Revenue Forecast (2022-2027)
7.3 Global Orphan Drugs Sales Volume, Revenue and Price Forecast by Type (2022-2027)
7.3.1 Global Orphan Drugs Revenue and Growth Rate of Oncologic Diseases (2022-2027)
7.3.2 Global Orphan Drugs Revenue and Growth Rate of Metabolic Diseases (2022-2027)
7.3.3 Global Orphan Drugs Revenue and Growth Rate of Hematologic and Immunologic Diseases (2022-2027)
7.3.4 Global Orphan Drugs Revenue and Growth Rate of Infectious Diseases (2022-2027)
7.3.5 Global Orphan Drugs Revenue and Growth Rate of Neurologic Diseases (2022-2027)
7.3.6 Global Orphan Drugs Revenue and Growth Rate of Other Rare Diseases (2022-2027)
7.4 Global Orphan Drugs Consumption Forecast by Application (2022-2027)
7.4.1 Global Orphan Drugs Consumption Value and Growth Rate of Non-Hodgkin Lymphoma(2022-2027)
7.4.2 Global Orphan Drugs Consumption Value and Growth Rate of Acute Myeloid Leukemia(2022-2027)
7.4.3 Global Orphan Drugs Consumption Value and Growth Rate of Cystic Fibrosis(2022-2027)
7.4.4 Global Orphan Drugs Consumption Value and Growth Rate of Glioma(2022-2027)
7.4.5 Global Orphan Drugs Consumption Value and Growth Rate of Pancreatic Cancer(2022-2027)
7.4.6 Global Orphan Drugs Consumption Value and Growth Rate of Ovarian Cancer(2022-2027)
7.4.7 Global Orphan Drugs Consumption Value and Growth Rate of Multiple Myeloma(2022-2027)
7.4.8 Global Orphan Drugs Consumption Value and Growth Rate of Duchenne Muscular Dystrophy(2022-2027)
7.4.9 Global Orphan Drugs Consumption Value and Growth Rate of Graft vs Host Disease(2022-2027)
7.4.10 Global Orphan Drugs Consumption Value and Growth Rate of Renal Cell Carcinoma(2022-2027)
7.4.11 Global Orphan Drugs Consumption Value and Growth Rate of Others(2022-2027)
7.5 Orphan Drugs Market Forecast Under COVID-19
8 ORPHAN DRUGS MARKET UPSTREAM AND DOWNSTREAM ANALYSIS
8.1 Orphan Drugs Industrial Chain Analysis
8.2 Key Raw Materials Suppliers and Price Analysis
8.3 Manufacturing Cost Structure Analysis
8.3.1 Labor Cost Analysis
8.3.2 Energy Costs Analysis
8.3.3 R&D Costs Analysis
8.4 Alternative Product Analysis
8.5 Major Distributors of Orphan Drugs Analysis
8.6 Major Downstream Buyers of Orphan Drugs Analysis
8.7 Impact of COVID-19 and the Russia-Ukraine war on the Upstream and Downstream in the Orphan Drugs Industry
9 PLAYERS PROFILES
9.1 F.Hoffman-La Roche AG
9.1.1 F.Hoffman-La Roche AG Basic Information, Manufacturing Base, Sales Region and Competitors
9.1.2 Orphan Drugs Product Profiles, Application and Specification
9.1.3 F.Hoffman-La Roche AG Market Performance (2017-2022)
9.1.4 Recent Development
9.1.5 SWOT Analysis
9.2 Shire PLC
9.2.1 Shire PLC Basic Information, Manufacturing Base, Sales Region and Competitors
9.2.2 Orphan Drugs Product Profiles, Application and Specification
9.2.3 Shire PLC Market Performance (2017-2022)
9.2.4 Recent Development
9.2.5 SWOT Analysis
9.3 AbbVie, Inc.
9.3.1 AbbVie, Inc. Basic Information, Manufacturing Base, Sales Region and Competitors
9.3.2 Orphan Drugs Product Profiles, Application and Specification
9.3.3 AbbVie, Inc. Market Performance (2017-2022)
9.3.4 Recent Development
9.3.5 SWOT Analysis
9.4 Celgene Corporation
9.4.1 Celgene Corporation Basic Information, Manufacturing Base, Sales Region and Competitors
9.4.2 Orphan Drugs Product Profiles, Application and Specification
9.4.3 Celgene Corporation Market Performance (2017-2022)
9.4.4 Recent Development
9.4.5 SWOT Analysis
9.5 Alexion
9.5.1 Alexion Basic Information, Manufacturing Base, Sales Region and Competitors
9.5.2 Orphan Drugs Product Profiles, Application and Specification
9.5.3 Alexion Market Performance (2017-2022)
9.5.4 Recent Development
9.5.5 SWOT Analysis
9.6 Sanofi
9.6.1 Sanofi Basic Information, Manufacturing Base, Sales Region and Competitors
9.6.2 Orphan Drugs Product Profiles, Application and Specification
9.6.3 Sanofi Market Performance (2017-2022)
9.6.4 Recent Development
9.6.5 SWOT Analysis
9.7 Johnson & Johnson Services, Inc.
9.7.1 Johnson & Johnson Services, Inc. Basic Information, Manufacturing Base, Sales Region and Competitors
9.7.2 Orphan Drugs Product Profiles, Application and Specification
9.7.3 Johnson & Johnson Services, Inc. Market Performance (2017-2022)
9.7.4 Recent Development
9.7.5 SWOT Analysis
9.8 Bayer
9.8.1 Bayer Basic Information, Manufacturing Base, Sales Region and Competitors
9.8.2 Orphan Drugs Product Profiles, Application and Specification
9.8.3 Bayer Market Performance (2017-2022)
9.8.4 Recent Development
9.8.5 SWOT Analysis
9.9 RegeneRX Biopharmaceuticals, Inc.
9.9.1 RegeneRX Biopharmaceuticals, Inc. Basic Information, Manufacturing Base, Sales Region and Competitors
9.9.2 Orphan Drugs Product Profiles, Application and Specification
9.9.3 RegeneRX Biopharmaceuticals, Inc. Market Performance (2017-2022)
9.9.4 Recent Development
9.9.5 SWOT Analysis
9.10 Brisol-Myers Squibb Company
9.10.1 Brisol-Myers Squibb Company Basic Information, Manufacturing Base, Sales Region and Competitors
9.10.2 Orphan Drugs Product Profiles, Application and Specification
9.10.3 Brisol-Myers Squibb Company Market Performance (2017-2022)
9.10.4 Recent Development
9.10.5 SWOT Analysis
9.11 Amryt Pharma PLC
9.11.1 Amryt Pharma PLC Basic Information, Manufacturing Base, Sales Region and Competitors
9.11.2 Orphan Drugs Product Profiles, Application and Specification
9.11.3 Amryt Pharma PLC Market Performance (2017-2022)
9.11.4 Recent Development
9.11.5 SWOT Analysis
9.12 Merck & Co. Inc.
9.12.1 Merck & Co. Inc. Basic Information, Manufacturing Base, Sales Region and Competitors
9.12.2 Orphan Drugs Product Profiles, Application and Specification
9.12.3 Merck & Co. Inc. Market Performance (2017-2022)
9.12.4 Recent Development
9.12.5 SWOT Analysis
9.13 Novartis AG
9.13.1 Novartis AG Basic Information, Manufacturing Base, Sales Region and Competitors
9.13.2 Orphan Drugs Product Profiles, Application and Specification
9.13.3 Novartis AG Market Performance (2017-2022)
9.13.4 Recent Development
9.13.5 SWOT Analysis
9.14 Pfizer Inc.
9.14.1 Pfizer Inc. Basic Information, Manufacturing Base, Sales Region and Competitors
9.14.2 Orphan Drugs Product Profiles, Application and Specification
9.14.3 Pfizer Inc. Market Performance (2017-2022)
9.14.4 Recent Development
9.14.5 SWOT Analysis
10 RESEARCH FINDINGS AND CONCLUSION
11 APPENDIX
11.1 Methodology
11.2 Research Data Source
1.1 Product Overview and Scope of Orphan Drugs Market
1.2 Orphan Drugs Market Segment by Type
1.2.1 Global Orphan Drugs Market Sales Volume and CAGR (%) Comparison by Type (2017-2027)
1.3 Global Orphan Drugs Market Segment by Application
1.3.1 Orphan Drugs Market Consumption (Sales Volume) Comparison by Application (2017-2027)
1.4 Global Orphan Drugs Market, Region Wise (2017-2027)
1.4.1 Global Orphan Drugs Market Size (Revenue) and CAGR (%) Comparison by Region (2017-2027)
1.4.2 United States Orphan Drugs Market Status and Prospect (2017-2027)
1.4.3 Europe Orphan Drugs Market Status and Prospect (2017-2027)
1.4.4 China Orphan Drugs Market Status and Prospect (2017-2027)
1.4.5 Japan Orphan Drugs Market Status and Prospect (2017-2027)
1.4.6 India Orphan Drugs Market Status and Prospect (2017-2027)
1.4.7 Southeast Asia Orphan Drugs Market Status and Prospect (2017-2027)
1.4.8 Latin America Orphan Drugs Market Status and Prospect (2017-2027)
1.4.9 Middle East and Africa Orphan Drugs Market Status and Prospect (2017-2027)
1.5 Global Market Size of Orphan Drugs (2017-2027)
1.5.1 Global Orphan Drugs Market Revenue Status and Outlook (2017-2027)
1.5.2 Global Orphan Drugs Market Sales Volume Status and Outlook (2017-2027)
1.6 Global Macroeconomic Analysis
1.7 The impact of the Russia-Ukraine war on the Orphan Drugs Market
2 INDUSTRY OUTLOOK
2.1 Orphan Drugs Industry Technology Status and Trends
2.2 Industry Entry Barriers
2.2.1 Analysis of Financial Barriers
2.2.2 Analysis of Technical Barriers
2.2.3 Analysis of Talent Barriers
2.2.4 Analysis of Brand Barrier
2.3 Orphan Drugs Market Drivers Analysis
2.4 Orphan Drugs Market Challenges Analysis
2.5 Emerging Market Trends
2.6 Consumer Preference Analysis
2.7 Orphan Drugs Industry Development Trends under COVID-19 Outbreak
2.7.1 Global COVID-19 Status Overview
2.7.2 Influence of COVID-19 Outbreak on Orphan Drugs Industry Development
3 GLOBAL ORPHAN DRUGS MARKET LANDSCAPE BY PLAYER
3.1 Global Orphan Drugs Sales Volume and Share by Player (2017-2022)
3.2 Global Orphan Drugs Revenue and Market Share by Player (2017-2022)
3.3 Global Orphan Drugs Average Price by Player (2017-2022)
3.4 Global Orphan Drugs Gross Margin by Player (2017-2022)
3.5 Orphan Drugs Market Competitive Situation and Trends
3.5.1 Orphan Drugs Market Concentration Rate
3.5.2 Orphan Drugs Market Share of Top 3 and Top 6 Players
3.5.3 Mergers & Acquisitions, Expansion
4 GLOBAL ORPHAN DRUGS SALES VOLUME AND REVENUE REGION WISE (2017-2022)
4.1 Global Orphan Drugs Sales Volume and Market Share, Region Wise (2017-2022)
4.2 Global Orphan Drugs Revenue and Market Share, Region Wise (2017-2022)
4.3 Global Orphan Drugs Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.4 United States Orphan Drugs Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.4.1 United States Orphan Drugs Market Under COVID-19
4.5 Europe Orphan Drugs Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.5.1 Europe Orphan Drugs Market Under COVID-19
4.6 China Orphan Drugs Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.6.1 China Orphan Drugs Market Under COVID-19
4.7 Japan Orphan Drugs Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.7.1 Japan Orphan Drugs Market Under COVID-19
4.8 India Orphan Drugs Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.8.1 India Orphan Drugs Market Under COVID-19
4.9 Southeast Asia Orphan Drugs Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.9.1 Southeast Asia Orphan Drugs Market Under COVID-19
4.10 Latin America Orphan Drugs Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.10.1 Latin America Orphan Drugs Market Under COVID-19
4.11 Middle East and Africa Orphan Drugs Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.11.1 Middle East and Africa Orphan Drugs Market Under COVID-19
5 GLOBAL ORPHAN DRUGS SALES VOLUME, REVENUE, PRICE TREND BY TYPE
5.1 Global Orphan Drugs Sales Volume and Market Share by Type (2017-2022)
5.2 Global Orphan Drugs Revenue and Market Share by Type (2017-2022)
5.3 Global Orphan Drugs Price by Type (2017-2022)
5.4 Global Orphan Drugs Sales Volume, Revenue and Growth Rate by Type (2017-2022)
5.4.1 Global Orphan Drugs Sales Volume, Revenue and Growth Rate of Oncologic Diseases (2017-2022)
5.4.2 Global Orphan Drugs Sales Volume, Revenue and Growth Rate of Metabolic Diseases (2017-2022)
5.4.3 Global Orphan Drugs Sales Volume, Revenue and Growth Rate of Hematologic and Immunologic Diseases (2017-2022)
5.4.4 Global Orphan Drugs Sales Volume, Revenue and Growth Rate of Infectious Diseases (2017-2022)
5.4.5 Global Orphan Drugs Sales Volume, Revenue and Growth Rate of Neurologic Diseases (2017-2022)
5.4.6 Global Orphan Drugs Sales Volume, Revenue and Growth Rate of Other Rare Diseases (2017-2022)
6 GLOBAL ORPHAN DRUGS MARKET ANALYSIS BY APPLICATION
6.1 Global Orphan Drugs Consumption and Market Share by Application (2017-2022)
6.2 Global Orphan Drugs Consumption Revenue and Market Share by Application (2017-2022)
6.3 Global Orphan Drugs Consumption and Growth Rate by Application (2017-2022)
6.3.1 Global Orphan Drugs Consumption and Growth Rate of Non-Hodgkin Lymphoma (2017-2022)
6.3.2 Global Orphan Drugs Consumption and Growth Rate of Acute Myeloid Leukemia (2017-2022)
6.3.3 Global Orphan Drugs Consumption and Growth Rate of Cystic Fibrosis (2017-2022)
6.3.4 Global Orphan Drugs Consumption and Growth Rate of Glioma (2017-2022)
6.3.5 Global Orphan Drugs Consumption and Growth Rate of Pancreatic Cancer (2017-2022)
6.3.6 Global Orphan Drugs Consumption and Growth Rate of Ovarian Cancer (2017-2022)
6.3.7 Global Orphan Drugs Consumption and Growth Rate of Multiple Myeloma (2017-2022)
6.3.8 Global Orphan Drugs Consumption and Growth Rate of Duchenne Muscular Dystrophy (2017-2022)
6.3.9 Global Orphan Drugs Consumption and Growth Rate of Graft vs Host Disease (2017-2022)
6.3.10 Global Orphan Drugs Consumption and Growth Rate of Renal Cell Carcinoma (2017-2022)
6.3.11 Global Orphan Drugs Consumption and Growth Rate of Others (2017-2022)
7 GLOBAL ORPHAN DRUGS MARKET FORECAST (2022-2027)
7.1 Global Orphan Drugs Sales Volume, Revenue Forecast (2022-2027)
7.1.1 Global Orphan Drugs Sales Volume and Growth Rate Forecast (2022-2027)
7.1.2 Global Orphan Drugs Revenue and Growth Rate Forecast (2022-2027)
7.1.3 Global Orphan Drugs Price and Trend Forecast (2022-2027)
7.2 Global Orphan Drugs Sales Volume and Revenue Forecast, Region Wise (2022-2027)
7.2.1 United States Orphan Drugs Sales Volume and Revenue Forecast (2022-2027)
7.2.2 Europe Orphan Drugs Sales Volume and Revenue Forecast (2022-2027)
7.2.3 China Orphan Drugs Sales Volume and Revenue Forecast (2022-2027)
7.2.4 Japan Orphan Drugs Sales Volume and Revenue Forecast (2022-2027)
7.2.5 India Orphan Drugs Sales Volume and Revenue Forecast (2022-2027)
7.2.6 Southeast Asia Orphan Drugs Sales Volume and Revenue Forecast (2022-2027)
7.2.7 Latin America Orphan Drugs Sales Volume and Revenue Forecast (2022-2027)
7.2.8 Middle East and Africa Orphan Drugs Sales Volume and Revenue Forecast (2022-2027)
7.3 Global Orphan Drugs Sales Volume, Revenue and Price Forecast by Type (2022-2027)
7.3.1 Global Orphan Drugs Revenue and Growth Rate of Oncologic Diseases (2022-2027)
7.3.2 Global Orphan Drugs Revenue and Growth Rate of Metabolic Diseases (2022-2027)
7.3.3 Global Orphan Drugs Revenue and Growth Rate of Hematologic and Immunologic Diseases (2022-2027)
7.3.4 Global Orphan Drugs Revenue and Growth Rate of Infectious Diseases (2022-2027)
7.3.5 Global Orphan Drugs Revenue and Growth Rate of Neurologic Diseases (2022-2027)
7.3.6 Global Orphan Drugs Revenue and Growth Rate of Other Rare Diseases (2022-2027)
7.4 Global Orphan Drugs Consumption Forecast by Application (2022-2027)
7.4.1 Global Orphan Drugs Consumption Value and Growth Rate of Non-Hodgkin Lymphoma(2022-2027)
7.4.2 Global Orphan Drugs Consumption Value and Growth Rate of Acute Myeloid Leukemia(2022-2027)
7.4.3 Global Orphan Drugs Consumption Value and Growth Rate of Cystic Fibrosis(2022-2027)
7.4.4 Global Orphan Drugs Consumption Value and Growth Rate of Glioma(2022-2027)
7.4.5 Global Orphan Drugs Consumption Value and Growth Rate of Pancreatic Cancer(2022-2027)
7.4.6 Global Orphan Drugs Consumption Value and Growth Rate of Ovarian Cancer(2022-2027)
7.4.7 Global Orphan Drugs Consumption Value and Growth Rate of Multiple Myeloma(2022-2027)
7.4.8 Global Orphan Drugs Consumption Value and Growth Rate of Duchenne Muscular Dystrophy(2022-2027)
7.4.9 Global Orphan Drugs Consumption Value and Growth Rate of Graft vs Host Disease(2022-2027)
7.4.10 Global Orphan Drugs Consumption Value and Growth Rate of Renal Cell Carcinoma(2022-2027)
7.4.11 Global Orphan Drugs Consumption Value and Growth Rate of Others(2022-2027)
7.5 Orphan Drugs Market Forecast Under COVID-19
8 ORPHAN DRUGS MARKET UPSTREAM AND DOWNSTREAM ANALYSIS
8.1 Orphan Drugs Industrial Chain Analysis
8.2 Key Raw Materials Suppliers and Price Analysis
8.3 Manufacturing Cost Structure Analysis
8.3.1 Labor Cost Analysis
8.3.2 Energy Costs Analysis
8.3.3 R&D Costs Analysis
8.4 Alternative Product Analysis
8.5 Major Distributors of Orphan Drugs Analysis
8.6 Major Downstream Buyers of Orphan Drugs Analysis
8.7 Impact of COVID-19 and the Russia-Ukraine war on the Upstream and Downstream in the Orphan Drugs Industry
9 PLAYERS PROFILES
9.1 F.Hoffman-La Roche AG
9.1.1 F.Hoffman-La Roche AG Basic Information, Manufacturing Base, Sales Region and Competitors
9.1.2 Orphan Drugs Product Profiles, Application and Specification
9.1.3 F.Hoffman-La Roche AG Market Performance (2017-2022)
9.1.4 Recent Development
9.1.5 SWOT Analysis
9.2 Shire PLC
9.2.1 Shire PLC Basic Information, Manufacturing Base, Sales Region and Competitors
9.2.2 Orphan Drugs Product Profiles, Application and Specification
9.2.3 Shire PLC Market Performance (2017-2022)
9.2.4 Recent Development
9.2.5 SWOT Analysis
9.3 AbbVie, Inc.
9.3.1 AbbVie, Inc. Basic Information, Manufacturing Base, Sales Region and Competitors
9.3.2 Orphan Drugs Product Profiles, Application and Specification
9.3.3 AbbVie, Inc. Market Performance (2017-2022)
9.3.4 Recent Development
9.3.5 SWOT Analysis
9.4 Celgene Corporation
9.4.1 Celgene Corporation Basic Information, Manufacturing Base, Sales Region and Competitors
9.4.2 Orphan Drugs Product Profiles, Application and Specification
9.4.3 Celgene Corporation Market Performance (2017-2022)
9.4.4 Recent Development
9.4.5 SWOT Analysis
9.5 Alexion
9.5.1 Alexion Basic Information, Manufacturing Base, Sales Region and Competitors
9.5.2 Orphan Drugs Product Profiles, Application and Specification
9.5.3 Alexion Market Performance (2017-2022)
9.5.4 Recent Development
9.5.5 SWOT Analysis
9.6 Sanofi
9.6.1 Sanofi Basic Information, Manufacturing Base, Sales Region and Competitors
9.6.2 Orphan Drugs Product Profiles, Application and Specification
9.6.3 Sanofi Market Performance (2017-2022)
9.6.4 Recent Development
9.6.5 SWOT Analysis
9.7 Johnson & Johnson Services, Inc.
9.7.1 Johnson & Johnson Services, Inc. Basic Information, Manufacturing Base, Sales Region and Competitors
9.7.2 Orphan Drugs Product Profiles, Application and Specification
9.7.3 Johnson & Johnson Services, Inc. Market Performance (2017-2022)
9.7.4 Recent Development
9.7.5 SWOT Analysis
9.8 Bayer
9.8.1 Bayer Basic Information, Manufacturing Base, Sales Region and Competitors
9.8.2 Orphan Drugs Product Profiles, Application and Specification
9.8.3 Bayer Market Performance (2017-2022)
9.8.4 Recent Development
9.8.5 SWOT Analysis
9.9 RegeneRX Biopharmaceuticals, Inc.
9.9.1 RegeneRX Biopharmaceuticals, Inc. Basic Information, Manufacturing Base, Sales Region and Competitors
9.9.2 Orphan Drugs Product Profiles, Application and Specification
9.9.3 RegeneRX Biopharmaceuticals, Inc. Market Performance (2017-2022)
9.9.4 Recent Development
9.9.5 SWOT Analysis
9.10 Brisol-Myers Squibb Company
9.10.1 Brisol-Myers Squibb Company Basic Information, Manufacturing Base, Sales Region and Competitors
9.10.2 Orphan Drugs Product Profiles, Application and Specification
9.10.3 Brisol-Myers Squibb Company Market Performance (2017-2022)
9.10.4 Recent Development
9.10.5 SWOT Analysis
9.11 Amryt Pharma PLC
9.11.1 Amryt Pharma PLC Basic Information, Manufacturing Base, Sales Region and Competitors
9.11.2 Orphan Drugs Product Profiles, Application and Specification
9.11.3 Amryt Pharma PLC Market Performance (2017-2022)
9.11.4 Recent Development
9.11.5 SWOT Analysis
9.12 Merck & Co. Inc.
9.12.1 Merck & Co. Inc. Basic Information, Manufacturing Base, Sales Region and Competitors
9.12.2 Orphan Drugs Product Profiles, Application and Specification
9.12.3 Merck & Co. Inc. Market Performance (2017-2022)
9.12.4 Recent Development
9.12.5 SWOT Analysis
9.13 Novartis AG
9.13.1 Novartis AG Basic Information, Manufacturing Base, Sales Region and Competitors
9.13.2 Orphan Drugs Product Profiles, Application and Specification
9.13.3 Novartis AG Market Performance (2017-2022)
9.13.4 Recent Development
9.13.5 SWOT Analysis
9.14 Pfizer Inc.
9.14.1 Pfizer Inc. Basic Information, Manufacturing Base, Sales Region and Competitors
9.14.2 Orphan Drugs Product Profiles, Application and Specification
9.14.3 Pfizer Inc. Market Performance (2017-2022)
9.14.4 Recent Development
9.14.5 SWOT Analysis
10 RESEARCH FINDINGS AND CONCLUSION
11 APPENDIX
11.1 Methodology
11.2 Research Data Source
LIST OF TABLES AND FIGURES
Figure Orphan Drugs Product Picture
Table Global Orphan Drugs Market Sales Volume and CAGR (%) Comparison by Type
Table Orphan Drugs Market Consumption (Sales Volume) Comparison by Application (2017-2027)
Figure Global Orphan Drugs Market Size (Revenue, Million USD) and CAGR (%) (2017-2027)
Figure United States Orphan Drugs Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Europe Orphan Drugs Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure China Orphan Drugs Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Japan Orphan Drugs Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure India Orphan Drugs Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Southeast Asia Orphan Drugs Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Latin America Orphan Drugs Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Middle East and Africa Orphan Drugs Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Global Orphan Drugs Market Sales Volume Status and Outlook (2017-2027)
Table Global Macroeconomic Analysis
Figure Global COVID-19 Status Overview
Table Influence of COVID-19 Outbreak on Orphan Drugs Industry Development
Table Global Orphan Drugs Sales Volume by Player (2017-2022)
Table Global Orphan Drugs Sales Volume Share by Player (2017-2022)
Figure Global Orphan Drugs Sales Volume Share by Player in 2021
Table Orphan Drugs Revenue (Million USD) by Player (2017-2022)
Table Orphan Drugs Revenue Market Share by Player (2017-2022)
Table Orphan Drugs Price by Player (2017-2022)
Table Orphan Drugs Gross Margin by Player (2017-2022)
Table Mergers & Acquisitions, Expansion Plans
Table Global Orphan Drugs Sales Volume, Region Wise (2017-2022)
Table Global Orphan Drugs Sales Volume Market Share, Region Wise (2017-2022)
Figure Global Orphan Drugs Sales Volume Market Share, Region Wise (2017-2022)
Figure Global Orphan Drugs Sales Volume Market Share, Region Wise in 2021
Table Global Orphan Drugs Revenue (Million USD), Region Wise (2017-2022)
Table Global Orphan Drugs Revenue Market Share, Region Wise (2017-2022)
Figure Global Orphan Drugs Revenue Market Share, Region Wise (2017-2022)
Figure Global Orphan Drugs Revenue Market Share, Region Wise in 2021
Table Global Orphan Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table United States Orphan Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Europe Orphan Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table China Orphan Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Japan Orphan Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table India Orphan Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Southeast Asia Orphan Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Latin America Orphan Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Middle East and Africa Orphan Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Global Orphan Drugs Sales Volume by Type (2017-2022)
Table Global Orphan Drugs Sales Volume Market Share by Type (2017-2022)
Figure Global Orphan Drugs Sales Volume Market Share by Type in 2021
Table Global Orphan Drugs Revenue (Million USD) by Type (2017-2022)
Table Global Orphan Drugs Revenue Market Share by Type (2017-2022)
Figure Global Orphan Drugs Revenue Market Share by Type in 2021
Table Orphan Drugs Price by Type (2017-2022)
Figure Global Orphan Drugs Sales Volume and Growth Rate of Oncologic Diseases (2017-2022)
Figure Global Orphan Drugs Revenue (Million USD) and Growth Rate of Oncologic Diseases (2017-2022)
Figure Global Orphan Drugs Sales Volume and Growth Rate of Metabolic Diseases (2017-2022)
Figure Global Orphan Drugs Revenue (Million USD) and Growth Rate of Metabolic Diseases (2017-2022)
Figure Global Orphan Drugs Sales Volume and Growth Rate of Hematologic and Immunologic Diseases (2017-2022)
Figure Global Orphan Drugs Revenue (Million USD) and Growth Rate of Hematologic and Immunologic Diseases (2017-2022)
Figure Global Orphan Drugs Sales Volume and Growth Rate of Infectious Diseases (2017-2022)
Figure Global Orphan Drugs Revenue (Million USD) and Growth Rate of Infectious Diseases (2017-2022)
Figure Global Orphan Drugs Sales Volume and Growth Rate of Neurologic Diseases (2017-2022)
Figure Global Orphan Drugs Revenue (Million USD) and Growth Rate of Neurologic Diseases (2017-2022)
Figure Global Orphan Drugs Sales Volume and Growth Rate of Other Rare Diseases (2017-2022)
Figure Global Orphan Drugs Revenue (Million USD) and Growth Rate of Other Rare Diseases (2017-2022)
Table Global Orphan Drugs Consumption by Application (2017-2022)
Table Global Orphan Drugs Consumption Market Share by Application (2017-2022)
Table Global Orphan Drugs Consumption Revenue (Million USD) by Application (2017-2022)
Table Global Orphan Drugs Consumption Revenue Market Share by Application (2017-2022)
Table Global Orphan Drugs Consumption and Growth Rate of Non-Hodgkin Lymphoma (2017-2022)
Table Global Orphan Drugs Consumption and Growth Rate of Acute Myeloid Leukemia (2017-2022)
Table Global Orphan Drugs Consumption and Growth Rate of Cystic Fibrosis (2017-2022)
Table Global Orphan Drugs Consumption and Growth Rate of Glioma (2017-2022)
Table Global Orphan Drugs Consumption and Growth Rate of Pancreatic Cancer (2017-2022)
Table Global Orphan Drugs Consumption and Growth Rate of Ovarian Cancer (2017-2022)
Table Global Orphan Drugs Consumption and Growth Rate of Multiple Myeloma (2017-2022)
Table Global Orphan Drugs Consumption and Growth Rate of Duchenne Muscular Dystrophy (2017-2022)
Table Global Orphan Drugs Consumption and Growth Rate of Graft vs Host Disease (2017-2022)
Table Global Orphan Drugs Consumption and Growth Rate of Renal Cell Carcinoma (2017-2022)
Table Global Orphan Drugs Consumption and Growth Rate of Others (2017-2022)
Figure Global Orphan Drugs Sales Volume and Growth Rate Forecast (2022-2027)
Figure Global Orphan Drugs Revenue (Million USD) and Growth Rate Forecast (2022-2027)
Figure Global Orphan Drugs Price and Trend Forecast (2022-2027)
Figure USA Orphan Drugs Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure USA Orphan Drugs Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Europe Orphan Drugs Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Europe Orphan Drugs Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure China Orphan Drugs Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure China Orphan Drugs Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Japan Orphan Drugs Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Japan Orphan Drugs Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure India Orphan Drugs Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure India Orphan Drugs Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Southeast Asia Orphan Drugs Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Southeast Asia Orphan Drugs Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Latin America Orphan Drugs Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Latin America Orphan Drugs Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Middle East and Africa Orphan Drugs Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Middle East and Africa Orphan Drugs Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Table Global Orphan Drugs Market Sales Volume Forecast, by Type
Table Global Orphan Drugs Sales Volume Market Share Forecast, by Type
Table Global Orphan Drugs Market Revenue (Million USD) Forecast, by Type
Table Global Orphan Drugs Revenue Market Share Forecast, by Type
Table Global Orphan Drugs Price Forecast, by Type
Figure Global Orphan Drugs Revenue (Million USD) and Growth Rate of Oncologic Diseases (2022-2027)
Figure Global Orphan Drugs Revenue (Million USD) and Growth Rate of Oncologic Diseases (2022-2027)
Figure Global Orphan Drugs Revenue (Million USD) and Growth Rate of Metabolic Diseases (2022-2027)
Figure Global Orphan Drugs Revenue (Million USD) and Growth Rate of Metabolic Diseases (2022-2027)
Figure Global Orphan Drugs Revenue (Million USD) and Growth Rate of Hematologic and Immunologic Diseases (2022-2027)
Figure Global Orphan Drugs Revenue (Million USD) and Growth Rate of Hematologic and Immunologic Diseases (2022-2027)
Figure Global Orphan Drugs Revenue (Million USD) and Growth Rate of Infectious Diseases (2022-2027)
Figure Global Orphan Drugs Revenue (Million USD) and Growth Rate of Infectious Diseases (2022-2027)
Figure Global Orphan Drugs Revenue (Million USD) and Growth Rate of Neurologic Diseases (2022-2027)
Figure Global Orphan Drugs Revenue (Million USD) and Growth Rate of Neurologic Diseases (2022-2027)
Figure Global Orphan Drugs Revenue (Million USD) and Growth Rate of Other Rare Diseases (2022-2027)
Figure Global Orphan Drugs Revenue (Million USD) and Growth Rate of Other Rare Diseases (2022-2027)
Table Global Orphan Drugs Market Consumption Forecast, by Application
Table Global Orphan Drugs Consumption Market Share Forecast, by Application
Table Global Orphan Drugs Market Revenue (Million USD) Forecast, by Application
Table Global Orphan Drugs Revenue Market Share Forecast, by Application
Figure Global Orphan Drugs Consumption Value (Million USD) and Growth Rate of Non-Hodgkin Lymphoma (2022-2027)
Figure Global Orphan Drugs Consumption Value (Million USD) and Growth Rate of Acute Myeloid Leukemia (2022-2027)
Figure Global Orphan Drugs Consumption Value (Million USD) and Growth Rate of Cystic Fibrosis (2022-2027)
Figure Global Orphan Drugs Consumption Value (Million USD) and Growth Rate of Glioma (2022-2027)
Figure Global Orphan Drugs Consumption Value (Million USD) and Growth Rate of Pancreatic Cancer (2022-2027)
Figure Global Orphan Drugs Consumption Value (Million USD) and Growth Rate of Ovarian Cancer (2022-2027)
Figure Global Orphan Drugs Consumption Value (Million USD) and Growth Rate of Multiple Myeloma (2022-2027)
Figure Global Orphan Drugs Consumption Value (Million USD) and Growth Rate of Duchenne Muscular Dystrophy (2022-2027)
Figure Global Orphan Drugs Consumption Value (Million USD) and Growth Rate of Graft vs Host Disease (2022-2027)
Figure Global Orphan Drugs Consumption Value (Million USD) and Growth Rate of Renal Cell Carcinoma (2022-2027)
Figure Global Orphan Drugs Consumption Value (Million USD) and Growth Rate of Others (2022-2027)
Figure Orphan Drugs Industrial Chain Analysis
Table Key Raw Materials Suppliers and Price Analysis
Figure Manufacturing Cost Structure Analysis
Table Alternative Product Analysis
Table Downstream Distributors
Table Downstream Buyers
Table F.Hoffman-La Roche AG Profile
Table F.Hoffman-La Roche AG Orphan Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure F.Hoffman-La Roche AG Orphan Drugs Sales Volume and Growth Rate
Figure F.Hoffman-La Roche AG Revenue (Million USD) Market Share 2017-2022
Table Shire PLC Profile
Table Shire PLC Orphan Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Shire PLC Orphan Drugs Sales Volume and Growth Rate
Figure Shire PLC Revenue (Million USD) Market Share 2017-2022
Table AbbVie, Inc. Profile
Table AbbVie, Inc. Orphan Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure AbbVie, Inc. Orphan Drugs Sales Volume and Growth Rate
Figure AbbVie, Inc. Revenue (Million USD) Market Share 2017-2022
Table Celgene Corporation Profile
Table Celgene Corporation Orphan Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Celgene Corporation Orphan Drugs Sales Volume and Growth Rate
Figure Celgene Corporation Revenue (Million USD) Market Share 2017-2022
Table Alexion Profile
Table Alexion Orphan Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Alexion Orphan Drugs Sales Volume and Growth Rate
Figure Alexion Revenue (Million USD) Market Share 2017-2022
Table Sanofi Profile
Table Sanofi Orphan Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Sanofi Orphan Drugs Sales Volume and Growth Rate
Figure Sanofi Revenue (Million USD) Market Share 2017-2022
Table Johnson & Johnson Services, Inc. Profile
Table Johnson & Johnson Services, Inc. Orphan Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Johnson & Johnson Services, Inc. Orphan Drugs Sales Volume and Growth Rate
Figure Johnson & Johnson Services, Inc. Revenue (Million USD) Market Share 2017-2022
Table Bayer Profile
Table Bayer Orphan Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Bayer Orphan Drugs Sales Volume and Growth Rate
Figure Bayer Revenue (Million USD) Market Share 2017-2022
Table RegeneRX Biopharmaceuticals, Inc. Profile
Table RegeneRX Biopharmaceuticals, Inc. Orphan Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure RegeneRX Biopharmaceuticals, Inc. Orphan Drugs Sales Volume and Growth Rate
Figure RegeneRX Biopharmaceuticals, Inc. Revenue (Million USD) Market Share 2017-2022
Table Brisol-Myers Squibb Company Profile
Table Brisol-Myers Squibb Company Orphan Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Brisol-Myers Squibb Company Orphan Drugs Sales Volume and Growth Rate
Figure Brisol-Myers Squibb Company Revenue (Million USD) Market Share 2017-2022
Table Amryt Pharma PLC Profile
Table Amryt Pharma PLC Orphan Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Amryt Pharma PLC Orphan Drugs Sales Volume and Growth Rate
Figure Amryt Pharma PLC Revenue (Million USD) Market Share 2017-2022
Table Merck & Co. Inc. Profile
Table Merck & Co. Inc. Orphan Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Merck & Co. Inc. Orphan Drugs Sales Volume and Growth Rate
Figure Merck & Co. Inc. Revenue (Million USD) Market Share 2017-2022
Table Novartis AG Profile
Table Novartis AG Orphan Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Novartis AG Orphan Drugs Sales Volume and Growth Rate
Figure Novartis AG Revenue (Million USD) Market Share 2017-2022
Table Pfizer Inc. Profile
Table Pfizer Inc. Orphan Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Pfizer Inc. Orphan Drugs Sales Volume and Growth Rate
Figure Pfizer Inc. Revenue (Million USD) Market Share 2017-2022
Figure Orphan Drugs Product Picture
Table Global Orphan Drugs Market Sales Volume and CAGR (%) Comparison by Type
Table Orphan Drugs Market Consumption (Sales Volume) Comparison by Application (2017-2027)
Figure Global Orphan Drugs Market Size (Revenue, Million USD) and CAGR (%) (2017-2027)
Figure United States Orphan Drugs Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Europe Orphan Drugs Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure China Orphan Drugs Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Japan Orphan Drugs Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure India Orphan Drugs Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Southeast Asia Orphan Drugs Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Latin America Orphan Drugs Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Middle East and Africa Orphan Drugs Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Global Orphan Drugs Market Sales Volume Status and Outlook (2017-2027)
Table Global Macroeconomic Analysis
Figure Global COVID-19 Status Overview
Table Influence of COVID-19 Outbreak on Orphan Drugs Industry Development
Table Global Orphan Drugs Sales Volume by Player (2017-2022)
Table Global Orphan Drugs Sales Volume Share by Player (2017-2022)
Figure Global Orphan Drugs Sales Volume Share by Player in 2021
Table Orphan Drugs Revenue (Million USD) by Player (2017-2022)
Table Orphan Drugs Revenue Market Share by Player (2017-2022)
Table Orphan Drugs Price by Player (2017-2022)
Table Orphan Drugs Gross Margin by Player (2017-2022)
Table Mergers & Acquisitions, Expansion Plans
Table Global Orphan Drugs Sales Volume, Region Wise (2017-2022)
Table Global Orphan Drugs Sales Volume Market Share, Region Wise (2017-2022)
Figure Global Orphan Drugs Sales Volume Market Share, Region Wise (2017-2022)
Figure Global Orphan Drugs Sales Volume Market Share, Region Wise in 2021
Table Global Orphan Drugs Revenue (Million USD), Region Wise (2017-2022)
Table Global Orphan Drugs Revenue Market Share, Region Wise (2017-2022)
Figure Global Orphan Drugs Revenue Market Share, Region Wise (2017-2022)
Figure Global Orphan Drugs Revenue Market Share, Region Wise in 2021
Table Global Orphan Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table United States Orphan Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Europe Orphan Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table China Orphan Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Japan Orphan Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table India Orphan Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Southeast Asia Orphan Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Latin America Orphan Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Middle East and Africa Orphan Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Global Orphan Drugs Sales Volume by Type (2017-2022)
Table Global Orphan Drugs Sales Volume Market Share by Type (2017-2022)
Figure Global Orphan Drugs Sales Volume Market Share by Type in 2021
Table Global Orphan Drugs Revenue (Million USD) by Type (2017-2022)
Table Global Orphan Drugs Revenue Market Share by Type (2017-2022)
Figure Global Orphan Drugs Revenue Market Share by Type in 2021
Table Orphan Drugs Price by Type (2017-2022)
Figure Global Orphan Drugs Sales Volume and Growth Rate of Oncologic Diseases (2017-2022)
Figure Global Orphan Drugs Revenue (Million USD) and Growth Rate of Oncologic Diseases (2017-2022)
Figure Global Orphan Drugs Sales Volume and Growth Rate of Metabolic Diseases (2017-2022)
Figure Global Orphan Drugs Revenue (Million USD) and Growth Rate of Metabolic Diseases (2017-2022)
Figure Global Orphan Drugs Sales Volume and Growth Rate of Hematologic and Immunologic Diseases (2017-2022)
Figure Global Orphan Drugs Revenue (Million USD) and Growth Rate of Hematologic and Immunologic Diseases (2017-2022)
Figure Global Orphan Drugs Sales Volume and Growth Rate of Infectious Diseases (2017-2022)
Figure Global Orphan Drugs Revenue (Million USD) and Growth Rate of Infectious Diseases (2017-2022)
Figure Global Orphan Drugs Sales Volume and Growth Rate of Neurologic Diseases (2017-2022)
Figure Global Orphan Drugs Revenue (Million USD) and Growth Rate of Neurologic Diseases (2017-2022)
Figure Global Orphan Drugs Sales Volume and Growth Rate of Other Rare Diseases (2017-2022)
Figure Global Orphan Drugs Revenue (Million USD) and Growth Rate of Other Rare Diseases (2017-2022)
Table Global Orphan Drugs Consumption by Application (2017-2022)
Table Global Orphan Drugs Consumption Market Share by Application (2017-2022)
Table Global Orphan Drugs Consumption Revenue (Million USD) by Application (2017-2022)
Table Global Orphan Drugs Consumption Revenue Market Share by Application (2017-2022)
Table Global Orphan Drugs Consumption and Growth Rate of Non-Hodgkin Lymphoma (2017-2022)
Table Global Orphan Drugs Consumption and Growth Rate of Acute Myeloid Leukemia (2017-2022)
Table Global Orphan Drugs Consumption and Growth Rate of Cystic Fibrosis (2017-2022)
Table Global Orphan Drugs Consumption and Growth Rate of Glioma (2017-2022)
Table Global Orphan Drugs Consumption and Growth Rate of Pancreatic Cancer (2017-2022)
Table Global Orphan Drugs Consumption and Growth Rate of Ovarian Cancer (2017-2022)
Table Global Orphan Drugs Consumption and Growth Rate of Multiple Myeloma (2017-2022)
Table Global Orphan Drugs Consumption and Growth Rate of Duchenne Muscular Dystrophy (2017-2022)
Table Global Orphan Drugs Consumption and Growth Rate of Graft vs Host Disease (2017-2022)
Table Global Orphan Drugs Consumption and Growth Rate of Renal Cell Carcinoma (2017-2022)
Table Global Orphan Drugs Consumption and Growth Rate of Others (2017-2022)
Figure Global Orphan Drugs Sales Volume and Growth Rate Forecast (2022-2027)
Figure Global Orphan Drugs Revenue (Million USD) and Growth Rate Forecast (2022-2027)
Figure Global Orphan Drugs Price and Trend Forecast (2022-2027)
Figure USA Orphan Drugs Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure USA Orphan Drugs Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Europe Orphan Drugs Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Europe Orphan Drugs Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure China Orphan Drugs Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure China Orphan Drugs Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Japan Orphan Drugs Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Japan Orphan Drugs Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure India Orphan Drugs Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure India Orphan Drugs Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Southeast Asia Orphan Drugs Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Southeast Asia Orphan Drugs Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Latin America Orphan Drugs Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Latin America Orphan Drugs Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Middle East and Africa Orphan Drugs Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Middle East and Africa Orphan Drugs Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Table Global Orphan Drugs Market Sales Volume Forecast, by Type
Table Global Orphan Drugs Sales Volume Market Share Forecast, by Type
Table Global Orphan Drugs Market Revenue (Million USD) Forecast, by Type
Table Global Orphan Drugs Revenue Market Share Forecast, by Type
Table Global Orphan Drugs Price Forecast, by Type
Figure Global Orphan Drugs Revenue (Million USD) and Growth Rate of Oncologic Diseases (2022-2027)
Figure Global Orphan Drugs Revenue (Million USD) and Growth Rate of Oncologic Diseases (2022-2027)
Figure Global Orphan Drugs Revenue (Million USD) and Growth Rate of Metabolic Diseases (2022-2027)
Figure Global Orphan Drugs Revenue (Million USD) and Growth Rate of Metabolic Diseases (2022-2027)
Figure Global Orphan Drugs Revenue (Million USD) and Growth Rate of Hematologic and Immunologic Diseases (2022-2027)
Figure Global Orphan Drugs Revenue (Million USD) and Growth Rate of Hematologic and Immunologic Diseases (2022-2027)
Figure Global Orphan Drugs Revenue (Million USD) and Growth Rate of Infectious Diseases (2022-2027)
Figure Global Orphan Drugs Revenue (Million USD) and Growth Rate of Infectious Diseases (2022-2027)
Figure Global Orphan Drugs Revenue (Million USD) and Growth Rate of Neurologic Diseases (2022-2027)
Figure Global Orphan Drugs Revenue (Million USD) and Growth Rate of Neurologic Diseases (2022-2027)
Figure Global Orphan Drugs Revenue (Million USD) and Growth Rate of Other Rare Diseases (2022-2027)
Figure Global Orphan Drugs Revenue (Million USD) and Growth Rate of Other Rare Diseases (2022-2027)
Table Global Orphan Drugs Market Consumption Forecast, by Application
Table Global Orphan Drugs Consumption Market Share Forecast, by Application
Table Global Orphan Drugs Market Revenue (Million USD) Forecast, by Application
Table Global Orphan Drugs Revenue Market Share Forecast, by Application
Figure Global Orphan Drugs Consumption Value (Million USD) and Growth Rate of Non-Hodgkin Lymphoma (2022-2027)
Figure Global Orphan Drugs Consumption Value (Million USD) and Growth Rate of Acute Myeloid Leukemia (2022-2027)
Figure Global Orphan Drugs Consumption Value (Million USD) and Growth Rate of Cystic Fibrosis (2022-2027)
Figure Global Orphan Drugs Consumption Value (Million USD) and Growth Rate of Glioma (2022-2027)
Figure Global Orphan Drugs Consumption Value (Million USD) and Growth Rate of Pancreatic Cancer (2022-2027)
Figure Global Orphan Drugs Consumption Value (Million USD) and Growth Rate of Ovarian Cancer (2022-2027)
Figure Global Orphan Drugs Consumption Value (Million USD) and Growth Rate of Multiple Myeloma (2022-2027)
Figure Global Orphan Drugs Consumption Value (Million USD) and Growth Rate of Duchenne Muscular Dystrophy (2022-2027)
Figure Global Orphan Drugs Consumption Value (Million USD) and Growth Rate of Graft vs Host Disease (2022-2027)
Figure Global Orphan Drugs Consumption Value (Million USD) and Growth Rate of Renal Cell Carcinoma (2022-2027)
Figure Global Orphan Drugs Consumption Value (Million USD) and Growth Rate of Others (2022-2027)
Figure Orphan Drugs Industrial Chain Analysis
Table Key Raw Materials Suppliers and Price Analysis
Figure Manufacturing Cost Structure Analysis
Table Alternative Product Analysis
Table Downstream Distributors
Table Downstream Buyers
Table F.Hoffman-La Roche AG Profile
Table F.Hoffman-La Roche AG Orphan Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure F.Hoffman-La Roche AG Orphan Drugs Sales Volume and Growth Rate
Figure F.Hoffman-La Roche AG Revenue (Million USD) Market Share 2017-2022
Table Shire PLC Profile
Table Shire PLC Orphan Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Shire PLC Orphan Drugs Sales Volume and Growth Rate
Figure Shire PLC Revenue (Million USD) Market Share 2017-2022
Table AbbVie, Inc. Profile
Table AbbVie, Inc. Orphan Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure AbbVie, Inc. Orphan Drugs Sales Volume and Growth Rate
Figure AbbVie, Inc. Revenue (Million USD) Market Share 2017-2022
Table Celgene Corporation Profile
Table Celgene Corporation Orphan Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Celgene Corporation Orphan Drugs Sales Volume and Growth Rate
Figure Celgene Corporation Revenue (Million USD) Market Share 2017-2022
Table Alexion Profile
Table Alexion Orphan Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Alexion Orphan Drugs Sales Volume and Growth Rate
Figure Alexion Revenue (Million USD) Market Share 2017-2022
Table Sanofi Profile
Table Sanofi Orphan Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Sanofi Orphan Drugs Sales Volume and Growth Rate
Figure Sanofi Revenue (Million USD) Market Share 2017-2022
Table Johnson & Johnson Services, Inc. Profile
Table Johnson & Johnson Services, Inc. Orphan Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Johnson & Johnson Services, Inc. Orphan Drugs Sales Volume and Growth Rate
Figure Johnson & Johnson Services, Inc. Revenue (Million USD) Market Share 2017-2022
Table Bayer Profile
Table Bayer Orphan Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Bayer Orphan Drugs Sales Volume and Growth Rate
Figure Bayer Revenue (Million USD) Market Share 2017-2022
Table RegeneRX Biopharmaceuticals, Inc. Profile
Table RegeneRX Biopharmaceuticals, Inc. Orphan Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure RegeneRX Biopharmaceuticals, Inc. Orphan Drugs Sales Volume and Growth Rate
Figure RegeneRX Biopharmaceuticals, Inc. Revenue (Million USD) Market Share 2017-2022
Table Brisol-Myers Squibb Company Profile
Table Brisol-Myers Squibb Company Orphan Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Brisol-Myers Squibb Company Orphan Drugs Sales Volume and Growth Rate
Figure Brisol-Myers Squibb Company Revenue (Million USD) Market Share 2017-2022
Table Amryt Pharma PLC Profile
Table Amryt Pharma PLC Orphan Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Amryt Pharma PLC Orphan Drugs Sales Volume and Growth Rate
Figure Amryt Pharma PLC Revenue (Million USD) Market Share 2017-2022
Table Merck & Co. Inc. Profile
Table Merck & Co. Inc. Orphan Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Merck & Co. Inc. Orphan Drugs Sales Volume and Growth Rate
Figure Merck & Co. Inc. Revenue (Million USD) Market Share 2017-2022
Table Novartis AG Profile
Table Novartis AG Orphan Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Novartis AG Orphan Drugs Sales Volume and Growth Rate
Figure Novartis AG Revenue (Million USD) Market Share 2017-2022
Table Pfizer Inc. Profile
Table Pfizer Inc. Orphan Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Pfizer Inc. Orphan Drugs Sales Volume and Growth Rate
Figure Pfizer Inc. Revenue (Million USD) Market Share 2017-2022
